Article Versions Notes

Mondielli G, Mougel G, Darriet F, Roche C, Querdray A, Lisbonis C, Appay R, Dufour H, Chinot O, Graillon T, et al. Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib. Cancers. 2022; 14(18):4448. https://doi.org/10.3390/cancers14184448

Mondielli, Gregoire, Gregory Mougel, Florent Darriet, Catherine Roche, Adeline Querdray, Christophe Lisbonis, Romain Appay, Henry Dufour, Olivier Chinot, Thomas Graillon, and et al. 2022. "Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib" Cancers 14, no. 18: 4448. https://doi.org/10.3390/cancers14184448

Mondielli, G., Mougel, G., Darriet, F., Roche, C., Querdray, A., Lisbonis, C., Appay, R., Dufour, H., Chinot, O., Graillon, T., & Barlier, A. (2022). Co-Targeting MAP Kinase and Pi3K-Akt-mTOR Pathways in Meningioma: Preclinical Study of Alpelisib and Trametinib. Cancers, 14(18), 4448. https://doi.org/10.3390/cancers14184448